Showing results (381-390 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|December 23, 2009
Molecular predictors of response to trastuzumab and lapatinib in breast cancerFrancisco J Esteva, Dihua Yu, Mien-Chie Hung, et al.Nature Reviews. Clinical Oncology|December 17, 2009
Genomic markers for decision making: what is preventing us from using markers?Vicky M Coyle, Patrick G JohnstonNature Reviews. Clinical Oncology|December 10, 2009
Innovations in the systemic therapy of prostate cancerDale R Shepard, Derek RaghavanNature Reviews. Clinical Oncology|September 21, 2018
Roles of the RANKL-RANK axis in antitumour immunity - implications for therapyElizabeth Ahern, Mark J Smyth, William C Dougall, et al.Nature Reviews. Clinical Oncology|October 3, 2018
Therapeutic strategies to target RAS-mutant cancersMeagan B Ryan, Ryan B CorcoranNature Reviews. Clinical Oncology|August 16, 2018
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?Gonzalo Recondo, Francesco Facchinetti, Ken A Olaussen, et al.Nature Reviews. Clinical Oncology|July 5, 2017
Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cellsHui K Gan, Martin van den Bent, Andrew B Lassman, et al.Nature Reviews. Clinical Oncology|May 26, 2019
Genetic alterations and their clinical implications in DLBCLYi Miao, L Jeffrey Medeiros, Yong Li, et al.Nature Reviews. Clinical Oncology|November 15, 2017
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapesAlexander Drilon, Zishuo I Hu, Gillianne G Y Lai, et al.Nature Reviews. Clinical Oncology|February 22, 2020
Current approaches to the management of brain metastasesJohn H Suh, Rupesh Kotecha, Samuel T Chao, et al.Pageof 97